Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
about
Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.The Multi-Step TB Diagnostic Cascade: More than Meets the Eye.Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping.Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis
P2860
Q33800939-D5DAAFDB-F14F-4876-8D7C-16BFFC5E6991Q38639403-8B7C5855-9242-4E68-86AB-95F20CCA653CQ40077837-AB29FEEB-21EF-4983-91D5-47D008B978DDQ40107565-5EC28D47-63E4-4B0D-847F-F9903211DCB4Q42687193-60B5A4A3-B0F0-48F0-9A3D-1ED499D27801Q46301624-EECD34B1-F511-4971-A20B-5A13EAB5511AQ46830811-02C8DDE7-EE88-4732-AFA9-E5949A8EA01DQ50044320-B0B0D13E-3DD4-4AA3-A74D-72C174073620Q51784776-3B1064C9-A394-4F2E-89A9-5B292F57F011Q55222894-BC46F373-83DD-48AC-AB96-DC83D1077D06Q55318227-1D9CC54A-6B97-4C41-957F-356A3677F3BDQ56669499-70938E91-75E7-4E8D-96AB-46E9E54F86BBQ58731377-22E2A3D7-FA04-4CDC-A75D-B313AE2DAA54
P2860
Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Delays and loss to follow-up b ...... A retrospective cohort study.
@ast
Delays and loss to follow-up b ...... A retrospective cohort study.
@en
type
label
Delays and loss to follow-up b ...... A retrospective cohort study.
@ast
Delays and loss to follow-up b ...... A retrospective cohort study.
@en
prefLabel
Delays and loss to follow-up b ...... A retrospective cohort study.
@ast
Delays and loss to follow-up b ...... A retrospective cohort study.
@en
P2093
P2860
P50
P1433
P1476
Delays and loss to follow-up b ...... A retrospective cohort study.
@en
P2093
Lindy Dickson-Hall
Norbert Ndjeka
Wendy Stevens
P2860
P304
P356
10.1371/JOURNAL.PMED.1002238
P407
P577
2017-02-21T00:00:00Z